Serge Leyvraz
Humboldt-Universität zu Berlin
ORCID: 0000-0002-5705-6799Also affiliated with Freie Universität Berlin, Charité - Universitätsmedizin Berlin
MedicineImmunology and Microbiology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 2 papers. Top paper: “Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion–Positive Lung Cancers”.
87 citations
Daniel S.W. Tan, Ulrik Lassen, Serge Leyvraz, Yongmei Liu, Jyoti D. Patel +10 more
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas
N/A
25 citations
Lin Shen, David S. Hong, Ray McDermott, Vicki L. Keedy, Michela Casanova +19 more